SomnoMed Limited (SOMNF)

Market Cap	113.51M +85.6%
Revenue (ttm)	73.10M +21.6%
Net Income	-2.27M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	55.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	7,383
Open	0.5149
Previous Close	0.4625
Day's Range	0.5149 - 0.5149
52-Week Range	0.3675 - 0.5149
Beta	0.92
RSI	54.80
Earnings Date	Feb 20, 2026

About SomnoMed

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper te...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 300
• Stock Exchange: OTCMKTS
• Ticker Symbol: SOMNF

Financial Performance

In fiscal year 2025, SomnoMed's revenue was 111.49 million, an increase of 21.65% compared to the previous year's 91.65 million. Losses were -3.46 million, -71.77% less than in 2024.

Financial numbers in AUD